HEADER LIPID BINDING PROTEIN 19-DEC-06 2E59 TITLE CRYSTAL STRUCTURE OF HUMAN MD-2 IN COMPLEX WITH LIPID IVA COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYMPHOCYTE ANTIGEN 96; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MD-2 PROTEIN, ESOP-1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LY96, ESOP1, MD2; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPIC9, PPICZA, PPIC6A KEYWDS INNATE IMMUNITY, LIPID-BINDING, LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR U.OHTO,Y.SATOW REVDAT 7 23-OCT-24 2E59 1 REMARK REVDAT 6 25-OCT-23 2E59 1 HETSYN REVDAT 5 29-JUL-20 2E59 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 13-JUL-11 2E59 1 VERSN REVDAT 3 14-APR-09 2E59 1 CONECT REVDAT 2 24-FEB-09 2E59 1 VERSN REVDAT 1 26-JUN-07 2E59 0 JRNL AUTH U.OHTO,K.FUKASE,K.MIYAKE,Y.SATOW JRNL TITL CRYSTAL STRUCTURES OF HUMAN MD-2 AND ITS COMPLEX WITH JRNL TITL 2 ANTIENDOTOXIC LIPID IVA JRNL REF SCIENCE V. 316 1632 2007 JRNL REFN ISSN 0036-8075 JRNL PMID 17569869 JRNL DOI 10.1126/SCIENCE.1139111 REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.500 REMARK 3 COMPLETENESS FOR RANGE (%) : 78.9 REMARK 3 NUMBER OF REFLECTIONS : 6291 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 297 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.21 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.27 REMARK 3 REFLECTION IN BIN (WORKING SET) : 184 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 31.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.1920 REMARK 3 BIN FREE R VALUE SET COUNT : 8 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1162 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 123 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.08000 REMARK 3 B22 (A**2) : 1.08000 REMARK 3 B33 (A**2) : -2.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.674 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.300 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1326 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1782 ; 1.495 ; 2.059 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 145 ; 6.597 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 53 ;33.862 ;24.340 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;16.278 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ; 8.002 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 197 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 921 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 554 ; 0.259 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 899 ; 0.344 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 134 ; 0.233 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 46 ; 0.255 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.218 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 725 ; 4.014 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1181 ; 6.072 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 601 ; 4.389 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 601 ; 6.181 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2E59 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000026241. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7629 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 27.720 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 11.20 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2E56 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG3350, 40MM NA-CITRATE, PH 5.4, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.44450 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 26.39750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 26.39750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.72225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 26.39750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 26.39750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 83.16675 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 26.39750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 26.39750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 27.72225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 26.39750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 26.39750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 83.16675 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 55.44450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O6 LP5 A 501 O5 LP4 A 601 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 27 -164.70 -105.44 REMARK 500 ASP A 38 -147.36 43.61 REMARK 500 GLN A 41 -162.33 -113.28 REMARK 500 LYS A 55 4.02 -69.42 REMARK 500 THR A 84 -13.52 68.59 REMARK 500 LYS A 89 150.89 -46.42 REMARK 500 ARG A 96 -128.45 -102.32 REMARK 500 SER A 98 -139.10 44.35 REMARK 500 LYS A 109 113.00 -33.38 REMARK 500 THR A 112 124.54 -38.55 REMARK 500 SER A 141 111.83 -19.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2E56 RELATED DB: PDB REMARK 900 THE SAME PROTEIN DBREF 2E59 A 17 160 UNP Q9Y6Y9 LY96_HUMAN 17 160 SEQRES 1 A 144 GLU ALA GLN LYS GLN TYR TRP VAL CYS ASN SER SER ASP SEQRES 2 A 144 ALA SER ILE SER TYR THR TYR CYS ASP LYS MET GLN TYR SEQRES 3 A 144 PRO ILE SER ILE ASN VAL ASN PRO CYS ILE GLU LEU LYS SEQRES 4 A 144 GLY SER LYS GLY LEU LEU HIS ILE PHE TYR ILE PRO ARG SEQRES 5 A 144 ARG ASP LEU LYS GLN LEU TYR PHE ASN LEU TYR ILE THR SEQRES 6 A 144 VAL ASN THR MET ASN LEU PRO LYS ARG LYS GLU VAL ILE SEQRES 7 A 144 CYS ARG GLY SER ASP ASP ASP TYR SER PHE CYS ARG ALA SEQRES 8 A 144 LEU LYS GLY GLU THR VAL ASN THR THR ILE SER PHE SER SEQRES 9 A 144 PHE LYS GLY ILE LYS PHE SER LYS GLY LYS TYR LYS CYS SEQRES 10 A 144 VAL VAL GLU ALA ILE SER GLY SER PRO GLU GLU MET LEU SEQRES 11 A 144 PHE CYS LEU GLU PHE VAL ILE LEU HIS GLN PRO ASN SER SEQRES 12 A 144 ASN MODRES 2E59 ASN A 26 ASN GLYCOSYLATION SITE MODRES 2E59 ASN A 114 ASN GLYCOSYLATION SITE HET NAG A 801 14 HET NAG A 901 14 HET LP5 A 501 48 HET LP4 A 601 47 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM LP5 (R)-((2R,3S,4R,5R,6R)-3-HYDROXY-2-(HYDROXYMETHYL)-5- HETNAM 2 LP5 ((R)-3-HYDROXYTETRADECANAMIDO)-6-(PHOSPHONOOXY) HETNAM 3 LP5 TETRAHYDRO-2H-PYRAN-4-YL) 3-HYDROXYTETRADECANOATE HETNAM LP4 2-DEOXY-3-O-[(3R)-3-HYDROXYTETRADECANOYL]-2-{[(3R)-3- HETNAM 2 LP4 HYDROXYTETRADECANOYL]AMINO}-4-O-PHOSPHONO-BETA-D- HETNAM 3 LP4 GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 4 LP5 C34 H66 N O12 P FORMUL 5 LP4 C34 H66 N O12 P FORMUL 6 HOH *89(H2 O) HELIX 1 1 TYR A 102 ALA A 107 5 6 SHEET 1 A 6 TYR A 22 ASN A 26 0 SHEET 2 A 6 ALA A 30 TYR A 36 -1 O ILE A 32 N CYS A 25 SHEET 3 A 6 GLU A 144 HIS A 155 -1 O LEU A 154 N SER A 31 SHEET 4 A 6 LYS A 130 SER A 139 -1 N ALA A 137 O LEU A 146 SHEET 5 A 6 TYR A 75 VAL A 82 -1 N TYR A 75 O ILE A 138 SHEET 6 A 6 MET A 85 ASN A 86 -1 O MET A 85 N VAL A 82 SHEET 1 B 6 TYR A 22 ASN A 26 0 SHEET 2 B 6 ALA A 30 TYR A 36 -1 O ILE A 32 N CYS A 25 SHEET 3 B 6 GLU A 144 HIS A 155 -1 O LEU A 154 N SER A 31 SHEET 4 B 6 LYS A 130 SER A 139 -1 N ALA A 137 O LEU A 146 SHEET 5 B 6 TYR A 75 VAL A 82 -1 N TYR A 75 O ILE A 138 SHEET 6 B 6 ARG A 90 VAL A 93 -1 O ARG A 90 N LEU A 78 SHEET 1 C 3 ILE A 44 ASN A 49 0 SHEET 2 C 3 SER A 57 TYR A 65 -1 O LEU A 60 N ASN A 49 SHEET 3 C 3 VAL A 113 PHE A 121 -1 O VAL A 113 N TYR A 65 SSBOND 1 CYS A 25 CYS A 51 1555 1555 2.02 SSBOND 2 CYS A 37 CYS A 148 1555 1555 2.04 SSBOND 3 CYS A 95 CYS A 105 1555 1555 2.04 LINK ND2 ASN A 26 C1 NAG A 801 1555 1555 1.45 LINK ND2 ASN A 114 C1 NAG A 901 1555 1555 1.43 LINK O6 LP5 A 501 C1 LP4 A 601 1555 1555 1.33 CISPEP 1 ASN A 49 PRO A 50 0 -9.37 CISPEP 2 SER A 141 PRO A 142 0 13.63 CRYST1 52.795 52.795 110.889 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018941 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018941 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009018 0.00000